Literature DB >> 12201376

Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire.

Ingmar H A Franken1, Vincent M Hendriksa, Wim van den Brink.   

Abstract

In the present study, the factor structure, internal consistency, and the concurrent validity of two heroin craving questionnaires are examined. The Desires for Drug Questionnaire (DDQ) measures three factors: desire and intention, negative reinforcement, and control. The Obsessive Compulsive Drug Use Scale (OCDUS) also measures three factors: thoughts about heroin and interference, desire and control, and resistance to thoughts and intention. Subjects were 102 Dutch patients who were currently in treatment for drug dependency. All proposed scales have good reliability and concurrent validity. Implementation of these instruments in both clinical and research field is advocated.

Entities:  

Mesh:

Year:  2002        PMID: 12201376     DOI: 10.1016/s0306-4603(01)00201-5

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  61 in total

1.  Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods.

Authors:  Nikie Korver; Piotr J Quee; Heleen B M Boos; Claudia J P Simons; Lieuwe de Haan
Journal:  Int J Methods Psychiatr Res       Date:  2012-03-15       Impact factor: 4.035

2.  Effect of craving induction on inhibitory control in opiate dependence.

Authors:  Antonio Verdejo-García; Dan I Lubman; Anne Schwerk; Kim Roffel; Raquel Vilar-López; Trudi Mackenzie; Murat Yücel
Journal:  Psychopharmacology (Berl)       Date:  2011-09-28       Impact factor: 4.530

3.  Why do young people consume marijuana? Extending motivational theory via the Dualistic Model of Passion.

Authors:  Alan K Davis; Brooke J Arterberry; Erin E Bonar; Kipling M Bohnert; Maureen A Walton
Journal:  Transl Issues Psychol Sci       Date:  2018-03

4.  Development and evaluation of the heroin abstainers' cue-sensitization questionnaire.

Authors:  Qian He; Yan Feng; Ying Wang; Zengzhen Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

5.  Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.

Authors:  Brian J Sherman; Aimee L McRae-Clark; Nathaniel L Baker; Susan C Sonne; Therese K Killeen; Kasie Cloud; Kevin M Gray
Journal:  Am J Addict       Date:  2017-02-02

6.  Individual differences in anterior cingulate activation associated with attentional bias predict cocaine use after treatment.

Authors:  Reshmi Marhe; Maartje Luijten; Ben J M van de Wetering; Marion Smits; Ingmar H A Franken
Journal:  Neuropsychopharmacology       Date:  2013-01-07       Impact factor: 7.853

7.  No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir.

Authors:  Matthew P Kosloski; Weihan Zhao; Armen Asatryan; Jens Kort; Pierre Geoffroy; Wei Liu
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

8.  Craving predicts opioid use in opioid-dependent patients initiating buprenorphine treatment: a longitudinal study.

Authors:  Judith I Tsui; Bradley J Anderson; David R Strong; Michael D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2014-02-12       Impact factor: 3.829

Review 9.  Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?

Authors:  Scott Mackey; Martin Paulus
Journal:  Neurosci Biobehav Rev       Date:  2012-12-17       Impact factor: 8.989

10.  Pharmacokinetic interaction between telaprevir and methadone.

Authors:  Rolf van Heeswijk; Peter Verboven; Ann Vandevoorde; Petra Vinck; Jan Snoeys; Griet Boogaerts; Els De Paepe; Rodica Van Solingen-Ristea; James Witek; Varun Garg
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.